Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.
about
The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunityIL-17 family: cytokines, receptors and signalingEffect of IL-17 receptor A blockade with brodalumab in inflammatory diseasesCytokines in psoriasisA GRHL3-regulated repair pathway suppresses immune-mediated epidermal hyperplasiaRadiation-Induced Dermatitis is Mediated by IL17-Expressing γδ T Cells.Early tissue responses in psoriasis to the antitumour necrosis factor-α biologic etanercept suggest reduced interleukin-17 receptor expression and signalling.IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms.Exacerbation of allergen-induced eczema in TLR4- and TRIF-deficient mice.Proteomics of skin proteins in psoriasis: from discovery and verification in a mouse model to confirmation in humans.Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis.Effects of baicalin cream in two mouse models: 2,4-dinitrofluorobenzene-induced contact hypersensitivity and mouse tail test for psoriasis.The danger model approach to the pathogenesis of the rheumatic diseases.Chronic, not acute, skin-specific inflammation promotes thrombosis in psoriasis murine modelsIL-17A, IL-22, IL-6, and IL-21 Serum Levels in Plaque-Type Psoriasis in Brazilian Patients.Diacerein inhibits the pro-atherogenic & pro-inflammatory effects of IL-1 on human keratinocytes & endothelial cells.Transgenic expression of human amphiregulin in mouse skin: inflammatory epidermal hyperplasia and enlarged sebaceous glands.Skin Immunity to Candida albicans.Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury.Epidermal Nbn deletion causes premature hair loss and a phenotype resembling psoriasiform dermatitis.Interleukin 6 regulates psoriasiform inflammation-associated thrombosis.Epidermal CD147 expression plays a key role in IL-22-induced psoriatic dermatitis.The role of IL-17 in psoriasis.Immature myeloid progenitors promote disease progression in a mouse model of Barrett's-like metaplasia.Ixekizumab for treatment of psoriasis.Use of brodalumab for the treatment of psoriasis and psoriatic arthritis.Targeting IL-17 with ixekizumab in patients with psoriasis.Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease.Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.Ixekizumab for treatment of adults with moderate-to-severe plaque psoriasis and psoriatic arthritis.Interleukin-19 as a translational indicator of renal injury.Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications.Identification of genes differentially expressed in menstrual breakdown and repair.IL-17A plays a central role in the expression of psoriasis signature genes through the induction of IκB-ζ in keratinocytes.Interleukin-17C in human Helicobacter pylori gastritis.Keratinocytes produce IL-17c to protect peripheral nervous systems during human HSV-2 reactivation.The pharmacodynamic impact of apremilast, an oral phosphodiesterase 4 inhibitor, on circulating levels of inflammatory biomarkers in patients with psoriatic arthritis: substudy results from a phase III, randomized, placebo-controlled trial (PALACE 1Regulation of Interleukin-17 Production.CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin.The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins.
P2860
Q26750673-5FEED087-4537-43A5-8D6A-A165AE8DBC17Q26860251-7B61645E-4DDB-4F2E-ADB7-7672AB881361Q28076496-29AF9459-1CB0-430E-B366-D5F754A7D682Q28255491-AD6D9059-5C41-496D-B860-9141A1222A10Q28587867-63970EBD-C2E5-466C-9F45-E282E68E8325Q33925159-825E8F3D-DF6E-4660-96CA-BDB1FCA7DCC5Q33969217-BB3B6ADB-9804-4753-9673-ECBAFE679138Q34082705-0FAF1A27-1375-440C-B92D-71595335A9EDQ34655780-D52B62DD-335A-456D-B4D9-5914D840C8F9Q34884113-EBD2FC0C-375D-49BE-A4E8-DF41E7860D21Q35301398-D87A9894-47C9-4AE3-BB8E-4EE2DCA3B488Q35480016-F4B8BEEF-D101-47E6-98E8-823AE45CE2F4Q35564107-20413109-D0DA-4CC3-9FE8-26286A0D371CQ35870923-88F43836-192B-4840-BB5D-92FE32423F91Q35999113-7992C501-D676-4A14-AF81-6DA10F0A1A51Q36316432-78380F6D-D230-4221-A7BF-23D3F372E850Q36679934-8514C259-A7C8-4E33-BD76-68E1E00B1B9AQ37062344-DFDF1E6D-8642-4495-90A9-D6B0EAFBD831Q37117847-7D16864E-A194-4962-9D1C-470C4F48F25AQ37268929-AF692045-E7B8-4D2A-8B9C-23ABB0FBC875Q37469175-E75DE78A-A488-4FA6-8F1C-F8202B9A7985Q37685970-2B2B1982-5B6F-4B6C-8182-875D826BD459Q38189480-4494A851-31FB-4E58-AE3E-2FAB989BFFD1Q38261210-D855731C-B437-4ABD-B2A2-963690B0C5FEQ38369782-BA4ADE48-9F2F-4869-BAEA-AEE07B6937EFQ38445314-283B620D-C491-4419-9DF7-B9EE6F13114BQ38633741-6B2BD9ED-0CDB-4AEA-AD89-56C6DB03390AQ38804875-31FF0B38-8DD5-4061-9C27-EB037537C64DQ38899075-D982F25E-CFCE-40BE-93F0-2719AA26655DQ38969026-95D4FE18-0BF2-421C-8555-5A4CCC730DD7Q39006188-01418258-095C-4392-8266-9D31234888B3Q39376982-C7E0A99B-D354-4901-BED8-C2EE41F7E327Q39408500-A802CACB-B38A-4B20-B642-F7928B820154Q39947458-6E6B1A0F-0AAA-44BB-8427-B1185F930342Q40121719-BEFE83DA-6637-4C2E-B6FA-34A403402085Q40140509-912A5D78-1E48-43EF-9D37-50B0BC54E1BDQ40204659-C4616E20-6F08-4E98-BF73-0814FF472212Q40508654-53E53A84-B25B-448B-9EC9-EF580FA522F6Q41133262-34102C69-EE33-418E-A91C-AA2E0A0E6CD7Q41459873-7C645641-BFAC-4796-AA23-F2B6C9D74A0F
P2860
Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.
@ast
Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.
@en
type
label
Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.
@ast
Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.
@en
prefLabel
Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.
@ast
Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.
@en
P2093
P2860
P356
P1476
Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.
@en
P2093
Andrew Johnston
Andrew M Guzman
Cynthia S Chen
Doina Diaconu
Johann E Gudjonsson
Paul M Al-Attar
Sean M Dawes
P2860
P304
P356
10.4049/JIMMUNOL.1201505
P407
P577
2013-01-28T00:00:00Z